Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.44 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 5/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.34 |
| ▸ | FDPS | P14324 | 4/20 | 0.34 |
| ▸ | FABP4 | P15090 | 1/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19678295 | 0.86 | NR1H4 (0.37) | NR1H4HRH4HRH3GGPS1FDPS | |
| SCHEMBL22059738 | 0.83 | NR1H4 (0.39) | NR1H4HRH4HRH3DGAT1FFAR1 | |
| SCHEMBL22059717 | 0.83 | NR1H4 (0.39) | NR1H4HRH4HRH3DGAT1FFAR1 | |
| SCHEMBL18623460 | 0.82 | L3MBTL1 (0.44) | NR1H4HRH4HRH3DGAT1FFAR1 | |
| SCHEMBL20629980 | 0.79 | NR1H4 (0.36) | NR1H4HRH4HRH3DGAT1FFAR1 | |
| SCHEMBL12563636 | 0.78 | GGPS1 (0.38) | GGPS1FDPS | |
| SCHEMBL2628187 | 0.78 | KDM4E (0.41) | NR1H4FABP4 | |
| SCHEMBL19678300 | 0.78 | CYP19A1 (0.39) | HRH4HRH3GGPS1 | |
| SCHEMBL22060200 | 0.78 | NAMPT (0.42) | NR1H4HRH4HRH3DGAT1FFAR1 | |
| SCHEMBL28759020 | 0.76 | CYP4F2 (0.43) | FABP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200172575-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2020-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200172575-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | KISS1R, VIP, NPY1R | NR1H4 1764/4885HRH4 3143/4885HRH3 2770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.